Featured Research

from universities, journals, and other organizations

'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban

Date:
March 16, 2011
Source:
BMJ-British Medical Journal
Summary:
A new legal high has emerged that seems to be replacing the banned substance mephedrone or "miaow miaow," warns a critical care paramedic in a new article.

A new legal high has emerged that seems to be replacing the banned substance mephedrone or "miaow miaow," warns a critical care paramedic in Emergency Medicine Journal.

Mephedrone was banned in England, when it was reclassified as a class B drug in April 2010.

The new drug in circulation is "ivory wave," also known as "purple wave," "ivory coast," or "vanilla sky." And its use has already been implicated in hospital admissions and deaths in various parts of England, says the author.

Ivory wave is usually sold online as bath salts in packets of between 200 and 500 mg, for 15 a pop. It can be snorted or swallowed.

"Whether or not this drug in fact contains illegal ingredients is as yet unclear," writes the author from the Southeast Coast Ambulance Service. "The drug's effects are concerning, however, and have been seen in patients in Lothian, Cumbria, Dorset and Essex."

The author describes in detail a case of ivory wave intoxication in a bid to raise awareness of a "drug which seems to be rapidly gaining popularity, " he says.

The case in question was a young man who had been detained in a police custody suite where he complained of sudden rapid heartbeat and chest pain. He was extremely agitated and anxious, hallucinating, and subject to involuntary facial contortions.

He was breathing very rapidly and had high blood pressure. He was given a drug normally used to treat episodes of angina and an anti-anxiety drug, in the belief that he had snorted coke.

This calmed him down, after which he admitted that he had snorted 2 g of ivory wave earlier that day.

Ivory wave can contain the stimulant methylenedioxypyrovalerone (MDPV) and the anaesthetic lignocaine, analysis has shown. But there doesn't seem to be any "set" recipe, says the author, so it can vary enormously in content. MDPV can have effects in doses as low as 5 mg.

Ivory wave's reported effects include initial euphoria, with other symptoms occurring up to a day after using, and lasting as long as a week.

These include overstimulation of the nervous and cardiovascular systems, resulting in acute paranoid psychosis, with extreme agitation, insomnia, dizziness, hyperthermia, and fitting, chest pains and variations in blood pressure that can damage the kidneys.

In some cases, the resulting agitation and paranoia have prompted patients to assault hospital staff, writes the author.

"It seems quite plausible that this drug could be the 'next mephedone'," suggests the author. "Reports reveal that its popularity has been [growing] and its use spreading across the UK in recent months."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Durham. Ivory wave: the next mephedrone? Emergency Medicine Journal, 2011; DOI: 10.1136/emj.2011.112920

Cite This Page:

BMJ-British Medical Journal. "'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban." ScienceDaily. ScienceDaily, 16 March 2011. <www.sciencedaily.com/releases/2011/03/110314184712.htm>.
BMJ-British Medical Journal. (2011, March 16). 'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/03/110314184712.htm
BMJ-British Medical Journal. "'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban." ScienceDaily. www.sciencedaily.com/releases/2011/03/110314184712.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins